A sandwiched microarray platform for benchtop cell-based high throughput screening

Biomaterials

Volumn 32, Issue 3, 2011, Pages 841-848

  Wu, Jinhui ^a,b,c   Wheeldon, Ian ^a,b   Guo, Yuqi ^a,b,d   Lu, Tingli ^a,b,e   Du, Yanan ^a,b   Wang, Ben ^a,b   He, Jiankang ^a,b   Hu, Yiqiao ^c   Khademhosseini, Ali ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c NANJING UNIVERSITY   (China)

^d ZHENGZHOU UNIVERSITY   (China)

^e NORTHWESTERN POLYTECHNICAL UNIVERSITY   (China)

Author keywords

Anti tumour; Biomedical; Camptothecin; Drug screening; Microscale engineering; Verapamil

Indexed keywords

ANTI-TUMOUR; BIOMEDICAL; CAMPTOTHECINS; DRUG SCREENING; MICRO-SCALES; VERAPAMIL;

ANIMAL CELL CULTURE; BIOACTIVITY; BIOASSAY; BIOCHIPS; BODY FLUIDS; CHEMICAL COMPOUNDS; CHEMICAL DETECTION; DRUG PRODUCTS; GLYCOPROTEINS; LIBRARIES; THROUGHPUT; TUMORS;

CELL CULTURE;

9 METHOXY CAMPTOTHECIN; CAMPTOTHECIN; NATURAL PRODUCT; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; BREAST CANCER; CANCER CELL; CELL ASSAY; CELL CULTURE; CELL VIABILITY; DRUG INTERACTION; FLUORESCENCE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL;

CAMPTOTHECIN; CELL LINE, TUMOR; CELL SURVIVAL; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG EVALUATION, PRECLINICAL; HUMANS; MICROSCOPY, ELECTRON, SCANNING; VERAPAMIL;

EID: 78549292063     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.09.026     Document Type: Article

References (37)

1. Bleicher K.H., Bohm H.J., Muller K., Alanine A.I. Hit and lead generation: beyond high-throughput screening. Nat Rev Drug Discov 2003, 2(5):369-378.
2. Geysen H.M., Schoenen F., Wagner D., Wagner R. Combinatorial compound libraries for drug discovery: an ongoing challenge. Nat Rev Drug Discov 2003, 2(3):222-230.
3. Butler M.S., Buss A.D. Natural products-The future scaffolds for novel antibiotics?. Biochem Pharmacol 2006, 71(7):919-929.
4. Schuster D., Laggner C., Langer T. Why drugs fail-a study on side effects in new chemical entities. Curr Pharm Des 2005, 11(27):3545-3559.
5. Li A.P. Screening for human ADME/Tox drug properties in drug discovery. Drug Discov Today 2001, 6(7):357-366.
6. Kremers P. In vitro tests for predicting drug-drug interactions: the need for Validated Procedures. Pharmacol Toxicol 2002, 91(5):209-217.
7. Bailey S.N., Sabatini D.M., Stockwell B.R. Microarrays of small molecules embedded in biodegradable polymers for use in mammalian cell-based screens. Proc Natl Acad Sci USA 2004, 101(46):16144-16149.
8. Tavana H., Jovic A., Mosadegh B., Lee Q.Y., Liu X., Luker K.E., et al. Nanolitre liquid patterning in aqueous environments for spatially defined reagent delivery to mammalian cells. Nat Mater 2009, 8(9):736-741.
9. Lee M.Y., Park C.B., Dordick J.S., Clark D.S. Metabolizing enzyme toxicology assay chip (MetaChip) for high-throughput microscale toxicity analyses. Proc Natl Acad Sci USA 2005, 102(4):983-987.
10. Lee M.Y., Kumar R.A., Sukumaran S.M., Hogg M.G., Clark D.S., Dordick J.S. Three-dimensional cellular microarray for high-throughput toxicology assays. Proc Natl Acad Sci USA 2008, 105(1):59-63.
11. Lii J., Hsu W.-J., Parsa H., Das A., Rouse R., Sia S.K. Real-time microfluidic system for studying mammalian cells in 3D microenvironments. Anal Chem 2008, 80(10):3640-3647.
12. Burns D.J., Kofron J.L., Warrior U., Beutel B.A. Well-less, gel-permeation formats for ultra-HTS. Drug Discov Today 2001, 6(12):S40-S47.
13. Ma B., Zhang G.H., Qin J.H., Lin B.C. Characterization of drug metabolites and cytotoxicity assay simultaneously using an integrated microfluidic device. Lab Chip 2009, 9(2):232-238.
14. Toh Y.C., Lim T.C., Tai D., Xiao G.F., van Noort D., Yu H.R. A microfluidic 3D hepatocyte chip for drug toxicity testing. Lab Chip 2009, 9(14):2026-2035.
15. Gosalia D.N., Diamond S.L. Printing chemical libraries on microarrays for fluid phase nanoliter reactions. Proc Natl Acad Sci USA 2003, 100(15):8721-8726.
16. David C.A., Middleton T., Montgomery D., Ben Lim H., Kati W., Molla A., et al. Microarray compound screening (mu ARCS) to identify inhibitors of HIV integrase. J Biomol Screen 2002, 7(3):259-266.
17. Lin J.H. Drug-drug interaction mediated by inhibition and induction of P-glycoprotein. Adv Drug Deliv Rev 2003, 55(1):53-81.
18. Dusseiller M.R., Schlaepfer D., Koch M., Kroschewski R., Textor M. An inverted microcontact printing method on topographically structured polystyrene chips for arrayed micro-3-D culturing of single cells. Biomaterials 2005, 26(29):5917-5925.
19. Yu S.T., Chern J.W., Chen T.M., Chiu Y.F., Chen H.T., Chen Y.H. Cytotoxicity and reversal of multidrug resistance by tryptanthrin-derived indoloquinazolines. Acta Pharmacologica Sinica 2010, 31(2):259-264.
20. Mehta G., Mehta K., Sud D., Song J.W., Bersano-Begey T., Futai N., et al. Quantitative measurement and control of oxygen levels in microfluidic poly(dimethylsiloxane) bioreactors during cell culture. Biomed Microdevices 2007, 9(2):123-134.
21. Zhang J.H., Chung T.D., Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999, 4(2):67-73.
22. Blum R.H., Carter S.K. Adriamycin. A new anticancer drug with significant clinical activity. Ann Intern Med 1974, 80(2):249-259.
23. Blum R.H., Carter S.K. Adriamycin. Ann Intern Med 1974, 80(2):249-259.
24. Hsiang Y.H., Hertzberg R., Hecht S., Liu L.F. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 1985, 260(27):4873-4878.
25. Hsiang Y.H., Liu L.F. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res 1988, 48(7):1722-1726.
26. Pommier Y. DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition. Chem Rev 2009, 109(7):2894-2902.
27. Kehrer D.F.S., Soepenberg O., Loos W.J., Verweij J., Sparreboom A. Modulation of camptothecin analogs in the treatment of cancer: a review. Anti-Cancer Drugs 2001, 12(2):89-105.
28. Wu S.F., Hsieh P.W., Wu C.C., Lee C.L., Chen S.L., Lu C.Y., et al. Camptothecinoids from the seeds of Taiwanese Nothapodytes foetida. Molecules 2008, 13(6):1361-1371.
29. Bansal T., Mishra G., Jaggi M., Khar R.K., Talegaonkar S. Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats. Eur J Pharm Sci 2009, 36(4-5):580-590.
30. Gupta R.K., Krishnamurti M. A prenylated chalkone from Milletia ovalifolia. Phytochemistry 1977, 16(2). 293-293.
31. Roy M., Mitra S.R., Bhattacharyya A., Adityachaudhury N. Candidone, a flavanone from Tephrosia candida. Phytochemistry 1986, 25(4):961-962.
32. Miyazawa M., Uemura T., Kameoka H. Biotransformation of sesquiterpenoids, (+)-aromadendrene and (-)-alloaromadendrene by Glomerella cingulata. Phytochemistry 1995, 40(3):793-796.
33. Moreno-Dorado F.J., Lamers Y.M.A.W., Mironov G., Wijnberg J.B.P.A., de Groot A. Chemistry of (+)-aromadendrene. Part 6: Rearrangement reactions of ledene, isoledene and their epoxides. Tetrahedron 2003, 59(39):7743-7750.
34. Robson R.A., Fraenkel M., Barratt L.J., Birkett D.J. Cyclosporin-verapamil interaction. Br J Clin Pharmacol 1988, 25(3):402-403.
35. Hedman A., Angelin B., Arvidsson A., Beck O., Dahlqvist R., Nilsson B., et al. Digoxin-verapamil interaction: Reduction of biliary but not renal digoxin clearance in humans. Clin Pharm Ther 1991, 49(3):256-262.
36. Maffia A., Kariv I., Oldenburg K. Miniaturization of a mammalian cell-based assay: luciferase reporter gene readout in a 3 microliter 1536-well plate. J Biomol Screen 1999, 4(3):137.
37. Berg M., Undisz K., Thiericke R., Moore T., Posten C. Miniaturization of a functional transcription assay in yeast (human progesterone receptor) in the 384-and 1536-well plate format. J Biomol Screen 2000, 5(2):71.